1.02
price up icon0.00%   0.00
after-market 시간 외 거래: 1.01 -0.01 -0.98%
loading

Adial Pharmaceuticals Inc 주식(ADIL)의 최신 뉴스

pulisher
Nov 16, 2024

Adial Pharmaceuticals (NASDAQ:ADIL) Coverage Initiated at Rodman & Renshaw - Defense World

Nov 16, 2024
pulisher
Nov 16, 2024

RODMAN&RENSHAW Upgrades Adial Pharmaceuticals (NASDAQ:ADIL) to “Strong-Buy” - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

Rodman & Renshaw sets stock target, buy rating on Adial Pharma, cites potential - Investing.com India

Nov 15, 2024
pulisher
Nov 14, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Adial Pharmaceutica - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

U.S. STOCKS Oklo, Adial Pharma, Sonos - XM

Nov 14, 2024
pulisher
Nov 14, 2024

EXCLUSIVE: Adial Pharmaceuticals Reveals Topline Results From Pharmacokinetics Study Of AD04 For Alcohol Use Disorder - AOL

Nov 14, 2024
pulisher
Nov 14, 2024

Adial Pharmaceuticals completes key study for FDA meeting - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

Adial Pharmaceuticals Announces Positive Topline Results - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

Adial Pharma's AD04 Drug Hits Key Milestones in Alcohol Use Disorder Treatment Study | ADIL Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

This Turning Point Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Nov 14, 2024
pulisher
Nov 14, 2024

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Update - Defense World

Nov 14, 2024
pulisher
Nov 14, 2024

Adial Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Nov 14, 2024
pulisher
Nov 13, 2024

Adial Pharma Reports Mixed Q3: AUD Drug Study Advances Despite Widening Losses | ADIL Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 07, 2024

Adial Pharmaceuticals Appoints Vinay Shah as CFO - Defense World

Nov 07, 2024
pulisher
Nov 06, 2024

Adial Pharmaceuticals names new CFO amid strategic growth By Investing.com - Investing.com Australia

Nov 06, 2024
pulisher
Nov 05, 2024

Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer - GlobeNewswire

Nov 05, 2024
pulisher
Nov 05, 2024

Adial Pharmaceuticals names new CFO amid strategic growth - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

Adial Pharma Taps Veteran CFO with $150M+ Fundraising Track Record | Key Executive Move | ADIL Stock News - StockTitan

Nov 05, 2024
pulisher
Oct 23, 2024

Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference - The Manila Times

Oct 23, 2024
pulisher
Oct 17, 2024

EXCLUSIVE: Adial Pharmaceuticals Secures Additional US Patent Expanding Intellectual Property Protection Around Its Alcohol Use Disorder Candidate - AOL

Oct 17, 2024
pulisher
Oct 17, 2024

Adial Pharmaceuticals patent expands for alcohol disorder drug - Investing.com

Oct 17, 2024
pulisher
Oct 17, 2024

Adial Pharmaceuticals patent expands for alcohol disorder drug By Investing.com - Investing.com Canada

Oct 17, 2024
pulisher
Oct 17, 2024

Adial Pharmaceuticals Receives Notice of Allowance for U.S. - GlobeNewswire

Oct 17, 2024
pulisher
Oct 15, 2024

Adial Pharmaceuticals Commends the National Institute on Alcohol Abuse and Alcoholism's New Definition of Recovery - GlobeNewswire

Oct 15, 2024
pulisher
Sep 26, 2024

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Down 46.2% in September - Defense World

Sep 26, 2024
pulisher
Sep 19, 2024

Analyzing ADI’s price-to-book ratio for the last quarter - US Post News

Sep 19, 2024
pulisher
Sep 19, 2024

Adial Pharmaceuticals completes key study stage for AUD drug - Investing.com

Sep 19, 2024
pulisher
Sep 19, 2024

Adial Pharmaceuticals Announces Database Lock in - GlobeNewswire

Sep 19, 2024
pulisher
Sep 19, 2024

Adial Pharmaceuticals Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder - StockTitan

Sep 19, 2024
pulisher
Sep 19, 2024

Analog Devices Inc. (ADI) Stock: A Year of Declines and Increases - The InvestChronicle

Sep 19, 2024
pulisher
Sep 19, 2024

MQS Management LLC Increases Stock Position in Analog Devices, Inc. (NASDAQ:ADI) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Addex Therapeutics Reports Profitable H1 2024 - TipRanks

Sep 19, 2024
pulisher
Sep 19, 2024

Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit - GlobeNewswire

Sep 19, 2024
pulisher
Sep 18, 2024

Recent Insider Activity Could Benefit Adaptimmune Therapeutics Plc ADR (ADAP) - Knox Daily

Sep 18, 2024
pulisher
Sep 18, 2024

ADMA Biologics stock soars to all-time high of $19.36 - Investing.com

Sep 18, 2024
pulisher
Sep 18, 2024

ADMA Biologics Stock Soars 76.2% in 3 Months: Right Time to Invest? - Yahoo Finance

Sep 18, 2024
pulisher
Sep 18, 2024

Adial Pharmaceuticals (NASDAQ:ADIL) versus Galapagos (NASDAQ:GLPG) Head-To-Head Comparison - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Analog Devices (NASDAQ:ADI) shareholders notch a 17% CAGR over 5 years, yet earnings have been shrinking - Yahoo Finance

Sep 18, 2024
pulisher
Sep 18, 2024

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement - Eagle-Tribune

Sep 18, 2024
pulisher
Sep 18, 2024

ADM Investor Services Singapore Becomes Abaxx Exchange's Third Clearing and Trading Member - GlobeNewswire

Sep 18, 2024
pulisher
Sep 18, 2024

Raymond James lifts Adma Biologics Inc [ADMA] price estimate. Who else is bullish? - The DBT News

Sep 18, 2024
pulisher
Sep 17, 2024

Keeping an Eye on Adma Biologics Inc (ADMA) After Insider Trading Activity - Knox Daily

Sep 17, 2024
pulisher
Sep 17, 2024

Adma Biologics Inc (NASDAQ:ADMA) stock crossing the finish line today - US Post News

Sep 17, 2024
pulisher
Sep 17, 2024

Analytical Overview: Adma Biologics Inc (ADMA)’s Ratios Tell a Financial Story - The Dwinnex

Sep 17, 2024
pulisher
Sep 17, 2024

A new trading data show Adaptimmune Therapeutics Plc ADR (ADAP) is showing positive returns. - SETE News

Sep 17, 2024
pulisher
Sep 17, 2024

ADIA Nutrition Stakes Claim in $6.7B Industry with Strategic Trademark Expansion - Marketscreener.com

Sep 17, 2024
pulisher
Sep 17, 2024

ADMA Biologics set to join S&P SmallCap 600 index By Investing.com - Investing.com Canada

Sep 17, 2024
pulisher
Sep 17, 2024

Take off with Applied Dna Sciences Inc (APDN): Get ready for trading - SETE News

Sep 17, 2024
pulisher
Sep 17, 2024

ADMA Biologics Set to Join S&P SmallCap 600 Index - Yahoo Finance

Sep 17, 2024
pulisher
Sep 16, 2024

Adma Biologics Inc (ADMA) Stock: The Story of a 52-Week Stock Range - The InvestChronicle

Sep 16, 2024
pulisher
Sep 16, 2024

Adma Biologics Inc (ADMA) Performance and Fundamentals Dashboard tells a completely different story - SETE News

Sep 16, 2024
pulisher
Sep 16, 2024

Predicting Adaptimmune Therapeutics Plc ADR’s (ADAP) earnings for the current quarter - US Post News

Sep 16, 2024
pulisher
Sep 16, 2024

Balance Sheet Insights: Applied Dna Sciences Inc (APDN)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Sep 16, 2024
pulisher
Sep 16, 2024

The Attractiveness of Investing In Analog Devices Inc. (ADI) is Growing - Knox Daily

Sep 16, 2024
pulisher
Sep 16, 2024

Applied Dna Sciences Inc (APDN) is a good investment, but the stock may be undervalued - US Post News

Sep 16, 2024
pulisher
Sep 16, 2024

Applied Dna Sciences Inc: Navigating Market Fluctuations with a 14.11M Market Cap - The InvestChronicle

Sep 16, 2024
pulisher
Sep 16, 2024

Small-cap stars are buying this forecast-smashing biotech - Citywire New Model Adviser

Sep 16, 2024
pulisher
Sep 16, 2024

Q2 2026 EPS Estimates for Analog Devices, Inc. Decreased by Analyst (NASDAQ:ADI) - MarketBeat

Sep 16, 2024
pulisher
Sep 16, 2024

Short Interest in Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Declines By 14.5% - Defense World

Sep 16, 2024
pulisher
Sep 15, 2024

Analog Devices (NASDAQ:ADI) shareholders notch a 16% CAGR over 5 years, yet earnings have been shrinking - Simply Wall St

Sep 15, 2024
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
자본화:     |  볼륨(24시간):